300 heart attack patients join quest for new prognostic markers

NCT ID NCT05794022

Recruiting now Knowledge-focused Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

First seen Feb 01, 2026 · Last updated May 22, 2026 · Updated 9 times

Summary

This study follows 300 adults who have had a severe type of heart attack (STEMI) to discover new biological and imaging markers that can predict heart function and recovery. Researchers will collect blood samples and perform MRI scans over one year, and track patients' health for up to five years. The goal is to build a research database to improve understanding and future treatment of heart attacks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOCARDIAL INFARCTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hospices Civils de Lyon - Hôpital Louis Pradel
RECRUITING

Bron, Rhone, 69500, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Hospices Civils de Lyon - Hôpital de la Croix Rousse
RECRUITING

Lyon, Rhone, 69004, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

MYOCARDIAL INFARCTION